CY1111541T1 - Αγωνιστες β-2 αδρενοϋποδοχεα για την αγωγη παθησεων συνδετικου ιστου του δερματος - Google Patents
Αγωνιστες β-2 αδρενοϋποδοχεα για την αγωγη παθησεων συνδετικου ιστου του δερματοςInfo
- Publication number
- CY1111541T1 CY1111541T1 CY20101100919T CY101100919T CY1111541T1 CY 1111541 T1 CY1111541 T1 CY 1111541T1 CY 20101100919 T CY20101100919 T CY 20101100919T CY 101100919 T CY101100919 T CY 101100919T CY 1111541 T1 CY1111541 T1 CY 1111541T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- skin
- conductive matter
- skin conductive
- adrenoceptor agonist
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000048 adrenergic agonist Substances 0.000 abstract 2
- 102000014974 beta2-adrenergic receptor activity proteins Human genes 0.000 abstract 2
- 108040006828 beta2-adrenergic receptor activity proteins Proteins 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 206010015150 Erythema Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000018631 connective tissue disease Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 231100000321 erythema Toxicity 0.000 abstract 1
- 206010025135 lupus erythematosus Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001235 sensitizing effect Effects 0.000 abstract 1
- 231100000121 skin sensitizing Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200500529 | 2005-04-13 | ||
| EP06007632A EP1719507B1 (en) | 2005-04-13 | 2006-04-12 | Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1111541T1 true CY1111541T1 (el) | 2015-08-05 |
Family
ID=36703472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20101100919T CY1111541T1 (el) | 2005-04-13 | 2010-10-14 | Αγωνιστες β-2 αδρενοϋποδοχεα για την αγωγη παθησεων συνδετικου ιστου του δερματος |
Country Status (28)
| Country | Link |
|---|---|
| US (4) | US8426475B2 (enExample) |
| EP (1) | EP1719507B1 (enExample) |
| JP (1) | JP5021621B2 (enExample) |
| KR (1) | KR101355422B1 (enExample) |
| CN (1) | CN101203214B (enExample) |
| AR (1) | AR054249A1 (enExample) |
| AT (1) | ATE473735T1 (enExample) |
| AU (1) | AU2006233502B2 (enExample) |
| BR (1) | BRPI0609361A2 (enExample) |
| CA (1) | CA2604758C (enExample) |
| CY (1) | CY1111541T1 (enExample) |
| DE (1) | DE602006015387D1 (enExample) |
| DK (1) | DK1719507T3 (enExample) |
| EA (1) | EA016082B1 (enExample) |
| ES (1) | ES2348920T3 (enExample) |
| HR (1) | HRP20100552T1 (enExample) |
| IL (1) | IL186491A (enExample) |
| MX (1) | MX2007012794A (enExample) |
| MY (1) | MY147864A (enExample) |
| NO (1) | NO331211B1 (enExample) |
| NZ (1) | NZ562940A (enExample) |
| PL (1) | PL1719507T3 (enExample) |
| PT (1) | PT1719507E (enExample) |
| RS (1) | RS51464B (enExample) |
| SI (1) | SI1719507T1 (enExample) |
| TW (1) | TWI366457B (enExample) |
| WO (1) | WO2006108424A2 (enExample) |
| ZA (1) | ZA200708748B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0604826D0 (en) * | 2006-03-09 | 2006-04-19 | Arakis Ltd | The treatment of inflammatory disorders and pain |
| MX2009000382A (es) | 2006-07-10 | 2009-01-27 | Intervet Int Bv | Composiciones de enantiomero zilpaterol y metodos para elaborar y usar tales composiciones. |
| GB0624757D0 (en) * | 2006-12-12 | 2007-01-17 | Sosei R & D Ltd | Novel compounds |
| GB0805535D0 (en) | 2008-03-27 | 2008-04-30 | Univ Leicester | Scar prevention |
| US20120252831A1 (en) * | 2011-03-31 | 2012-10-04 | Mustafa Nevzat Ilac Sanayii A.S. | Compositions of opioid antagonists and methods for treating scleroderma therewith |
| CN102267917B (zh) * | 2011-06-15 | 2013-07-31 | 浙江工业大学 | 一种盐酸甲氧那明的合成方法 |
| UA115445C2 (uk) * | 2012-05-18 | 2017-11-10 | Інтервет Інтернешнл Б.В. | Спосіб збільшення приросту бройлерних курей |
| GB2513297A (en) * | 2013-03-08 | 2014-10-29 | Univ Leicester | Methods |
| CN104606177B (zh) * | 2014-11-21 | 2018-02-02 | 苏州君宁新药开发中心有限公司 | 左旋(r)沙丁胺醇制剂在治疗皮肤及粘膜创伤溃疡的药物应用 |
| WO2018000098A1 (en) * | 2016-06-30 | 2018-01-04 | Cipher Pharmaceuticals Inc. | Treatment of inflammatory myopathies |
| CN106580978A (zh) * | 2016-11-30 | 2017-04-26 | 郑州仁宏医药科技有限公司 | 一种治疗皮炎的西药组合物及其应用 |
| US10576043B2 (en) * | 2017-08-10 | 2020-03-03 | Avro Life Sciences, Inc. | Transdermal drug delivery system |
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201903832D0 (en) | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
| US10947196B2 (en) * | 2019-03-27 | 2021-03-16 | Curasen Therapeutics, Inc. | Beta adrenergic agonist and methods of using the same |
| US11607395B2 (en) | 2019-12-18 | 2023-03-21 | Curasen Therapeutics, Inc. | Methods for improving neurological diseases and disorders |
| CN112300237A (zh) * | 2020-04-13 | 2021-02-02 | 苏州恩泰新材料科技有限公司 | 海豹胆酸的制备方法及其应用 |
| BR112023005697A2 (pt) * | 2020-10-09 | 2023-04-25 | Mc2 Therapeutics Ltd | Tratamento de condições dermatológicas |
| US20240043499A1 (en) | 2022-08-07 | 2024-02-08 | Protean Bio, Inc. | Peptides for beta-cell survival and insulin production |
| CN116236467B (zh) * | 2023-02-07 | 2023-10-27 | 中国人民解放军总医院 | 西马特罗或其衍生物的新用途 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA7464B (en) | 1973-01-16 | 1974-11-27 | J Voorhees | Treatment of proliferating skin diseases with papavine alkaloids |
| US4284623A (en) * | 1979-11-09 | 1981-08-18 | Beck Lee R | Method of treating inflammation using bovine milk |
| SU895445A1 (ru) * | 1980-05-15 | 1982-01-07 | Военно-Медицинская Краснознаменная Академия Им. С.М.Кирова | Способ лечени кожных форм красной волчанки |
| US4574129A (en) | 1984-01-31 | 1986-03-04 | Bristol-Myers Company | Topical nonsteroidal anti-inflammatory methods |
| JPS61154201A (ja) | 1984-12-26 | 1986-07-12 | Matsushita Electric Ind Co Ltd | 誘電体フイルタ |
| US4699777A (en) | 1985-08-21 | 1987-10-13 | Schering Corporation | Compositions and method for enhancement of the transdermal flux of albuterol with a combination of 1-dodecyl-azacyclopheptan-2-one and urea |
| PH25150A (en) | 1986-06-05 | 1991-03-13 | Ciba Geigy Ag | Novel pharmaceutical preparation for topical application |
| US4980159A (en) | 1989-05-23 | 1990-12-25 | Bristol-Myers Squibb Company | Processes and compositions for the topical application of β-adrenergic agonists for pilomotor effects |
| RU2092105C1 (ru) * | 1989-11-20 | 1997-10-10 | Нижегородский научно-исследовательский кожно-венерологический институт | Способ определения терапевтической тактики у больных очаговой склеродермией и дискоидной красной волчанкой |
| DE4014252A1 (de) * | 1990-05-04 | 1991-11-07 | Boehringer Ingelheim Vetmed | Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer |
| US5919827A (en) | 1990-07-11 | 1999-07-06 | Sepracor Inc. | Method for treating asthma using optically pure R(-) salmeterol |
| ES2084825T3 (es) | 1990-07-26 | 1996-05-16 | Monsanto Co | Procedimiento de preparacion de poliamidas entrecruzadas. |
| US5795564A (en) | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| GB9107196D0 (en) * | 1991-04-05 | 1991-05-22 | Sandoz Ag | Improvements in or relating to organic compounds |
| JP3294876B2 (ja) | 1992-07-20 | 2002-06-24 | トキコ株式会社 | 給油装置 |
| WO1995019336A1 (de) | 1994-01-12 | 1995-07-20 | Iovis Biomedical And Pharmaceutical Consultants | Phenylethanolaminether und ihre verwendung als beta-adrenorezeptor-agonisten |
| JPH07304647A (ja) | 1994-05-09 | 1995-11-21 | Kao Corp | マッサージ用組成物 |
| GB9422306D0 (en) * | 1994-11-04 | 1994-12-21 | Sandoz Ltd | Organic compounds |
| GB9510162D0 (en) * | 1995-05-19 | 1995-07-12 | Bouras Elias | Compositions for the treatment of skin conditions |
| JPH09110674A (ja) | 1995-10-16 | 1997-04-28 | Kao Corp | 浴用剤組成物 |
| FR2740040B1 (fr) | 1995-10-23 | 1997-12-05 | Oreal | Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p |
| EP0979081A4 (en) * | 1997-04-30 | 2003-05-02 | Bridge Pharma Inc | COMPOSITION AND METHODS USING EUTOMER |
| US6254882B1 (en) | 1997-09-16 | 2001-07-03 | Sepracor Inc. | Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol |
| WO2002018395A1 (en) * | 2000-08-31 | 2002-03-07 | Merck & Co., Inc. | Phosphate derivatives as immunoregulatory agents |
| WO2002040021A2 (en) | 2000-11-17 | 2002-05-23 | Idenix (Cayman) Limited | Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
| HUP0402577A3 (en) | 2001-12-03 | 2011-05-30 | Wyeth Corp | Indole derivatives as inhibitors of cytosolic phospholipase a2, process for producing them and pharmaceutical compositions containing them |
| CN1646143A (zh) * | 2002-04-19 | 2005-07-27 | 艾升发展公司 | β－2肾上腺素受体兴奋剂与氨基糖的结合及其在治疗免疫功能紊乱方面的应用 |
| AU2003228133A1 (en) | 2002-04-22 | 2003-11-03 | Umc Utrecht Holding B.V. | Reduction of unwanted immune reactions |
| WO2003092617A2 (en) | 2002-05-03 | 2003-11-13 | Combinatorx, Incorporated | Combinations for the treatment of inflammatory skin disorders |
| DE10224888A1 (de) | 2002-06-05 | 2003-12-24 | Merck Patent Gmbh | Pyridazinderivate |
| US20040229849A1 (en) | 2002-09-24 | 2004-11-18 | Jost-Price Edward Roydon | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| US20040220153A1 (en) * | 2002-09-24 | 2004-11-04 | Jost-Price Edward Roydon | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| EP1553955A4 (en) * | 2002-09-24 | 2008-11-05 | Combinatorx Inc | METHODS AND REAGENTS FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH INCREASED LEVELS OF PRO-INFLAMMATORY CYTOKINES |
| ES2401079T3 (es) | 2002-12-20 | 2013-04-16 | Amgen Inc. | Moduladores del asma y de la inflamación alérgica |
| TW200902047A (en) * | 2003-02-14 | 2009-01-16 | Combinatorx Inc | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| US20040209850A1 (en) * | 2003-04-15 | 2004-10-21 | Theraquest Biosciences, Llc | Methods of treating pain and compositions for use therefor |
| EP1646370A1 (en) | 2003-07-11 | 2006-04-19 | Glaxo Group Limited | Pharmaceutical formulations |
| TW200522932A (en) | 2003-09-15 | 2005-07-16 | Combinatorx Inc | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| JP2007512337A (ja) * | 2003-11-21 | 2007-05-17 | コンビナトアールエックス インコーポレーティッド | 炎症性障害の治療のための方法および試薬 |
| WO2005089741A2 (en) | 2004-03-17 | 2005-09-29 | Sosei R&D Ltd. | The treatment of inflammatory disorders and pain using beta-aminoalcohols |
| WO2005102296A2 (en) | 2004-04-23 | 2005-11-03 | Heptagen Limited | Combinations for the treatment of immunoproliferative skin disorders such as psoriasis |
| EP1786410A2 (en) * | 2004-09-07 | 2007-05-23 | Sosei R&D Ltd. | The treatment of inflammatory disorders and pain |
-
2006
- 2006-04-12 WO PCT/DK2006/050013 patent/WO2006108424A2/en not_active Ceased
- 2006-04-12 CA CA2604758A patent/CA2604758C/en not_active Expired - Fee Related
- 2006-04-12 AR AR20060101443A patent/AR054249A1/es not_active Application Discontinuation
- 2006-04-12 KR KR1020077026406A patent/KR101355422B1/ko not_active Expired - Fee Related
- 2006-04-12 EP EP06007632A patent/EP1719507B1/en not_active Expired - Lifetime
- 2006-04-12 DE DE602006015387T patent/DE602006015387D1/de not_active Expired - Lifetime
- 2006-04-12 ES ES06007632T patent/ES2348920T3/es not_active Expired - Lifetime
- 2006-04-12 BR BRPI0609361-2A patent/BRPI0609361A2/pt not_active Application Discontinuation
- 2006-04-12 RS RSP-2010/0442A patent/RS51464B/sr unknown
- 2006-04-12 PT PT06007632T patent/PT1719507E/pt unknown
- 2006-04-12 TW TW095112980A patent/TWI366457B/zh not_active IP Right Cessation
- 2006-04-12 SI SI200630807T patent/SI1719507T1/sl unknown
- 2006-04-12 AT AT06007632T patent/ATE473735T1/de active
- 2006-04-12 NZ NZ562940A patent/NZ562940A/en not_active IP Right Cessation
- 2006-04-12 AU AU2006233502A patent/AU2006233502B2/en not_active Ceased
- 2006-04-12 CN CN2006800165347A patent/CN101203214B/zh not_active Expired - Fee Related
- 2006-04-12 JP JP2008505738A patent/JP5021621B2/ja not_active Expired - Fee Related
- 2006-04-12 MX MX2007012794A patent/MX2007012794A/es active IP Right Grant
- 2006-04-12 EA EA200702204A patent/EA016082B1/ru not_active IP Right Cessation
- 2006-04-12 US US11/402,255 patent/US8426475B2/en not_active Expired - Fee Related
- 2006-04-12 MY MYPI20061656A patent/MY147864A/en unknown
- 2006-04-12 PL PL06007632T patent/PL1719507T3/pl unknown
- 2006-04-12 DK DK06007632.0T patent/DK1719507T3/da active
-
2007
- 2007-10-08 IL IL186491A patent/IL186491A/en active IP Right Grant
- 2007-10-12 ZA ZA200708748A patent/ZA200708748B/xx unknown
- 2007-11-02 NO NO20075527A patent/NO331211B1/no not_active IP Right Cessation
-
2010
- 2010-10-11 HR HR20100552T patent/HRP20100552T1/hr unknown
- 2010-10-14 CY CY20101100919T patent/CY1111541T1/el unknown
-
2013
- 2013-04-22 US US13/867,796 patent/US20130237607A1/en not_active Abandoned
-
2017
- 2017-02-23 US US15/440,803 patent/US9907765B2/en not_active Expired - Fee Related
-
2018
- 2018-12-21 US US16/228,920 patent/US20190125699A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111797T1 (el) | Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων | |
| CY1112376T1 (el) | Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2 | |
| EA200702204A1 (ru) | Лечение заболеваний соединительной ткани кожи | |
| CY1121781T1 (el) | Φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης της ρασαγιλινης και χρησεις αυτων | |
| CY1116075T1 (el) | Νεες συνθεσεις λιποσωματων | |
| CY1115082T1 (el) | Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων | |
| CY1116464T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
| CY1110199T1 (el) | Φαρμακευτικες συνθεσεις ενος νευροδραστικου στεροειδους και χρησεις αυτων | |
| CY1114863T1 (el) | Στερεο παρασκευασμα | |
| DOP2002000429A (es) | Imidazotriazinas | |
| ATE452129T1 (de) | N-phenyl-2-pyrimidine-amine derivatives | |
| PA8592301A1 (es) | Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
| CY1117656T1 (el) | Επιλογες θεραπειας για τη νοσο του fabry | |
| CY1113003T1 (el) | Ευσταθη παρασκευασματα laquinimod | |
| BRPI0510428A (pt) | composições tópicas de metadona e processos para utilização das mesmas | |
| CY1106589T1 (el) | (s)-2-ν-προπυλαμινο-5-υδροξυτετραλινη ως d3-αγωνιστικο θεραπευτικο μεσο | |
| CY1117326T1 (el) | Παραγωγο κατεχολαμινης χρησιμο για τη θεραπεια ασθενειας parkinson | |
| CY1105362T1 (el) | Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα | |
| EP1819227A4 (en) | PHARMACEUTICAL FORMULATIONS OF DECITABIN | |
| CY1113116T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
| CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
| ECSP045353A (es) | Derivados de benzoxazinona, su preparación y aplicación como medicamentos | |
| CY1109361T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
| CY1108684T1 (el) | Φαρμακευτικες συνθεσεις που περιλαμβανουν ασκορβικο οξυ για τη θεραπεια μυκητοειδων υπερμολυνσεων και μυκητοειδων επανεμφανισεων | |
| CY1109537T1 (el) | Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης |